From the bench.

NAD+ 500mg sat snug in the carton insert with clear strength print.

Parcel that arrived had tidy packing and readable vial stickers.

Stood the box on its side briefly; foam still pinned the vials when I opened it.

Thin outer envelope, sturdy box underneath — the inner one did the protecting.

Short drop-off note was followed: parcel under the porch roof, dry and closed.

BPC-157 10mg glass undamaged, label straight.

BPC-157 10mg print clear under the lamp; seals closed.

Held two vials to the light together — neither showed chips at the shoulder.

NAD+ 500mg box kept its shape. Foam still felt even.

GHK-Cu 50mg sat steady in the insert and the labels were clearly readable.

NAD+ 500mg arrived within the stated window. Caps were on properly.

Label ink hadn’t rubbed off in transit. Product names were still crisp.

Support listed serial positions on the slip; vials followed that left-to-right order.

They said not to worry about outer cosmetic marks; inner presentation was clean.

One outer flap printed with handling icons; arrows still visible.

Noted the dispatch day, noted the arrival day, noted intact seals — checklist done.

Tirzepatide 10mg clips kept each vial from moving.

Counted eight vials from a multi-item order; all present, none cracked.

Counted packing peanuts for fun; more than last time, vials quieter in the box.

Tirzepatide 10mg sat in the centre wells, empties on the sides — sensible packing choice.